ASX
Neuren Pharmaceuticals
NEU:ASX•Healthcare
Sensitive ASX Announcement
Q3 2026 DAYBUE net sales up 39%, full year guidance upgraded
Published: 05/11/26, 09:57am (AEST)•4 pages